Intimation under Regulation 30 read with clause 8 of Para B Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
MEDPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Medplus Health Services Limited has submitted a disclosure to the stock exchanges under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, read with clause 8 of Para B, Part A of Schedule III. This regulatory clause is typically used by listed companies to disclose information about dividends or other shareholder-distribution matters. The full text of the intimation was not provided, so the specific details, amounts, record dates, or payment dates are not available in this filing summary. Investors should refer to the full document on the NSE/BSE corporate filings page for complete information.
Without the detailed contents, the precise impact on shareholders cannot be determined. If this pertains to a dividend declaration, it could be a positive signal indicating returns to shareholders, but shareholders should review the full filing for specifics on dividend amount, record date, and payment timeline.